This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Paolisso, G. Articles by Varricchio, M. Search for Related Content PubMed PubMed Citation Articles by Paolisso, G. Articles by Varricchio, M.

Serum Levels of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 in Healthy Centenarians: Relationship with Plasma Leptin and Lipid Concentrations, Insulin Action, and Cognitive Function

Department of Geriatric Medicine and Metabolic Diseases, Institute of Endocrinology (A.D.B., M.R., C.C.), II University of Naples, Naples, Italy

Address all correspondence and requests for reprints to: Giuseppe Paolisso, M.D., Department of Geriatric Medicine and Metabolic Diseases, Servizio di Astanteria Medica, Piazza Miraglia 2, I-80138 Naples, Italy.

It has been demonstrated that healthy centenarians have more favorable anthropometric characteristics and insulin-mediated glucose uptake than aged subjects. The plasma insulin-like-growth factor I (IGF-I) concentration may account for such differences. Three groups of subjects were studied: 1) adults (<50 yr; n = 30), 2) aged subjects (75–99 yr; n = 30), 3) centenarians (>100 yr; n = 19). In all subjects, fasting plasma IGF-I, IGF-binding protein-3 (IGFBP-3), leptin, and lipid concentrations were determined; body composition was assessed by bioimpedance analysis; and insulin-mediated glucose uptake was evaluated by euglycemic hyperinsulinemic glucose clamp. IGF-I declined with advancing age, but no differences between aged subjects and centenarians were found. IGFBP-3 showed a trend similar to IGF-I, but lower values were present in centenarians than in aged subjects. Nevertheless, centenarians had a plasma IGF-I/IGFBP-3 molar ratio greater than that in aged subjects. Centenarians had also a whole body glucose disposal (WBGD) greater than that in aged subjects, but similar to that in adults. Mini Mental State Examination (27 ± 2.1 vs. 18.3 ± 3.1; P < 0.02) and Instrumental Activities Daily Living (26 ± 2.6 vs. 8.4 ± 4.1; P < 0.001) scores were significantly different in aged subjects and centenarians, respectively. In centenarians, the plasma IGF-I/IGFBP-3 molar ratio correlated with the body mass index (r = -0.55; P < 0.009); the amount of body fat (r = -0.62; P < 0.003); fat-free mass (r = 0.56; P < 0.008); fasting plasma leptin (r = -0.63; P < 0.004), triglycerides (r = -0.58; P < 0.01), free fatty acid (r = -0.64; P < 0.005), and low density lipoprotein cholesterol (r = -0.59; P < 0.009) concentrations; Mini Mental State Examination (r = 0.53; P < 0.0.03); and WBGD (r = 0.64; P < 0.005). All correlations were independent of daily fat and carbohydrate intake and WBGD (P < 0.05 for all). No significant correlations between the plasma IGF-I/IGFBP-3 molar ratio and plasma total (r = 0.31; P = NS) and high density lipoprotein cholesterol (r = 0.34; P = NS) concentrations were present. The correlation between the plasma IGF-I/IGFBP-3 molar ratio and WBGD persisted after adjustment for body fat, fasting plasma insulin concentration, daily carbohydrate and fat intake, and daily physical activity (r = 0.55; P < 0.009), but not after further adjustment for plasma free fatty acid concentration (r = 0.30; P = 0.17). In conclusion, healthy centenarians have plasma IGF-I/IGFBP-3 molar ratios greater than aged subjects. A more elevated plasma IGF-I/IGFBP-3 molar ratio might improve insulin action and plasma lipid concentration in centenarians.

This article has been cited by other articles:

				Q. Li, S. Wu, S.-Y. Li, F. L. Lopez, M. Du, J. Kajstura, P. Anversa, and J. Ren Cardiac-specific overexpression of insulin-like growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1398 - H1403. [Abstract] [Full Text] [PDF]

				O. I. Okereke, J. H. Kang, J. Ma, J. M. Gaziano, and F. Grodstein Midlife Plasma Insulin-Like Growth Factor I and Cognitive Function in Older Men J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4306 - 4312. [Abstract] [Full Text] [PDF]

				M. R. Rizzo, D. Mari, M. Barbieri, E. Ragno, R. Grella, R. Provenzano, I. Villa, K. Esposito, D. Giugliano, and G. Paolisso Resting Metabolic Rate and Respiratory Quotient in Human Longevity J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 409 - 413. [Abstract] [Full Text] [PDF]

				E. Conti, C. Carrozza, E. Capoluongo, M. Volpe, F. Crea, C. Zuppi, and F. Andreotti Insulin-Like Growth Factor-1 as a Vascular Protective Factor Circulation, October 12, 2004; 110(15): 2260 - 2265. [Full Text] [PDF]

				M. Barbieri, M. Bonafe, C. Franceschi, and G. Paolisso Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1064 - E1071. [Abstract] [Full Text] [PDF]

				M. T.B. Twickler, M.-J. M. Cramer, H. P.F. Koppeschaar, J. Malik, T. Stulc, R. Ceska, E. Conti, F. Crea, F. Andreotti, A. Juul, et al. Unraveling Reaven's Syndrome X: Serum Insulin-Like Growth Factor-I and Cardiovascular Disease * Response Circulation, May 27, 2003; 107 (20): e190 - e192. [Full Text] [PDF]

				P. Imbeault, J. B. Prins, M. Stolic, A. W. Russell, T. O'Moore-Sullivan, J.-P. Despres, C. Bouchard, and A. Tremblay Aging Per Se Does Not Influence Glucose Homeostasis: In vivo and in vitro evidence Diabetes Care, February 1, 2003; 26(2): 480 - 484. [Abstract] [Full Text] [PDF]

				S. S. C. Yen Dehydroepiandrosterone sulfate and longevity: New clues for an old friend PNAS, July 17, 2001; 98(15): 8167 - 8169. [Full Text] [PDF]

				H. Christou, J. M. Connors, M. Ziotopoulou, V. Hatzidakis, E. Papathanassoglou, S. A. Ringer, and C. S. Mantzoros Cord Blood Leptin and Insulin-Like Growth Factor Levels are Independent Predictors of Fetal Growth J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 935 - 938. [Abstract] [Full Text]

				Y. Arai, N. Hirose, K. Yamamura, K.-i. Shimizu, M. Takayama, Y. Ebihara, and Y. Osono Serum Insulin-like Growth Factor-1 in Centenarians: Implications of IGF-1 as a Rapid Turnover Protein J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2001; 56(2): 79M - 82. [Abstract] [Full Text]

				S. Kalmijn, J. A. M. J. L. Janssen, H. A. P. Pols, S. W. J. Lamberts, and M. M. B. Breteler A Prospective Study on Circulating Insulin-Like Growth Factor I (IGF-I), IGF-Binding Proteins, and Cognitive Function in the Elderly J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4551 - 4555. [Abstract] [Full Text]

				G. GARIBOTTO, A. BARRECA, A. SOFIA, R. RUSSO, F. FIORINI, G. CAPPELLI, F. CAVATORTA, A. CESARONE, R. FRANCESCHINI, P. SACCO, et al. Effects of Growth Hormone on Leptin Metabolism and Energy Expenditure in Hemodialysis Patients with Protein-Calorie Malnutrition J. Am. Soc. Nephrol., November 1, 2000; 11(11): 2106 - 2113. [Abstract] [Full Text]

				B. R. Lackey, S. L. Gray, and D. M. Henricks Does the Insulin-Like Growth Factor System Interact with Prostaglandins and Proinflammatory Cytokines During Neurodegeneration? Experimental Biology and Medicine, May 1, 2000; 224(1): 20 - 27. [Abstract] [Full Text]

				R. B. S. Harris Parabiosis between db/db and ob/ob or db/+ Mice Endocrinology, January 1, 1999; 140(1): 138 - 145. [Abstract] [Full Text]

				M. Miyakawa, T. Tsushima, H. Murakami, O. Isozaki, H. Demura, and T. Tanaka Effect of Growth Hormone (GH) on Serum Concentrations of Leptin: Study in Patients with Acromegaly and GH Deficiency J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3476 - 3479. [Abstract] [Full Text]

				R. Roubenoff, L. C. Rall, J. D. Veldhuis, J. J. Kehayias, C. Rosen, M. Nicolson, N. Lundgren, and S. Reichlin The Relationship between Growth Hormone Kinetics and Sarcopenia in Postmenopausal Women: The Role of Fat Mass and Leptin J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1502 - 1506. [Abstract] [Full Text]